Independent editorial research · not a seller or clinic
Evidence-Based Guidance on Pentadeca Arginate and Recovery
ArginateCare reviews what the research actually shows about Pentadeca Arginate (PDA) and the related peptide BPC-157. We grade the evidence honestly, keep established medical care separate from unproven claims, and never present animal studies as human proof.
Where the evidence stands
Pentadeca Arginate is not an established or FDA-approved treatment. We found no peer-reviewed studies of PDA itself; the research people cite is about BPC-157 and is largely preclinical. BPC-157 is an unapproved drug and is prohibited in sport. This site is educational and is not medical advice.
Start here
Complete PDA guide
The central evidence and safety guide to Pentadeca Arginate.
Conditions
Musculoskeletal, digestive, and pain or nerve conditions, graded by evidence.
Research
What the PDA and BPC-157 literature does and does not show.
Safety
Regulatory status, known concerns, and when to seek care.
Comparisons
How PDA compares to BPC-157 and TB-500 — as research, not a buying guide.
Explore condition research
Musculoskeletal
Digestive